Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- ELISA [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- Ab175532 - Provider product page
- Provider
- Aladdin Scientific
- Product name
- Epratuzumab (anti-CD22)
- Antibody type
- Recombinant
- Description
- Epratuzumab (anti-CD22) is an anti-CD22 IgG1 monoclonal antibody. Epratuzumab (anti-CD22) is also a tumor-imaging agent and an immunomodulatory agent. Epratuzumab (anti-CD22) can induce CD22 phosphorylation. Epratuzumab (anti-CD22) has been used to research non-HodgkinÕs lymphomas (NHL) and certain autoimmune diseases.
- Reactivity
- Human
- Conjugate
- Unconjugated
- Vial size
- 100_g,10mg,1mg,5mg
- Concentration
- Lot by Lot
- Storage
- Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
No comments: Submit comment
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Epratuzumab (anti-CD22) (Ab175532) - ELISA Immobilized Recombinant Human Siglec-2/CD22 Protein (rp169575) at 1.0 μg/mL can bind Epratuzumab (anti-CD22) (Ab175532) with the EC₅₀ of 207.0 ng/mL.
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Epratuzumab (anti-CD22) (Ab175532) - Flow Cytometry Flow Cytometry analysis of Raji cells labelling CD22 (red) with Epratuzumab (anti-CD22) (Ab175532). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
